Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Stable extended release oral dosage composition comprising loratadine and pseudoephedrine|
|Abstract:||A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.|
|Inventor(s):||Kwan; Henry K. (Summit, NJ), Liebowitz; Stephen M. (Neshanic Station, NJ)|
|Assignee:||Schering Corporation (Kenilworth, NJ)|
Patent Claim Types:|
see list of patent claims
|Composition; Use; Dosage form;|
|Country||Document Number||Publication Date|
|Austria||161420||Jan 15, 1998|
|Australia||5405094||May 24, 1994|
|Australia||676229||Mar 06, 1997|
|Canada||2147606||May 11, 1994|
|China, Peoples Republic of||1038474||May 27, 1998|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.